NCCN Updates Recommendations for COVID-19 Vaccination
NCCN has updated its recommendations on COVID-19 vaccination to include advice about bivalent vaccines, vaccinating immunocompromised children, and more.
All articles by Leah Lawrence
Breast Cancer Updates From ESMO 2022
Results from the TROPiCS-02, DATA, GIM2, and METEORA-II trials may help inform the treatment of breast cancer.
No Survival Benefit With T-VEC in Advanced Melanoma
Adding T-VEC to pembrolizumab does not improve survival in patients with advanced melanoma, a phase 3 study suggests.
Many Sponsors Don’t Share Data From Trials Supporting Cancer Drug Approvals
Many clinical trials supporting cancer drug approvals are ineligible for individual participant data sharing, a new study suggests.
USPSTF: Do Not Take Vitamin E, Beta Carotene to Prevent Cancer
Vitamin E does not decrease the risk of cancer or cancer-related death, and the risk of harm from beta carotene outweighs any potential benefits, according to the USPSTF.
New Cancer Diagnosis Linked to Increased Risk of Cardiovascular Death
A new cancer diagnosis is independently associated with a higher risk of cardiovascular death, stroke, heart failure, and pulmonary embolism.
1 in 5 Cancer Patients on Phase 3 Trials Use Complementary Medicine
The most common complementary medicines were herbal/natural products, dietary supplements, fish oils, glucosamine, and homeopathic medicines.
Study Supports Cervical Cancer Screening After Age 65
About 63% of patients were diagnosed with stage II or higher disease.
Genomic-Based Targeted Therapy Improved PFS for Certain Metastatic Breast Cancers
The researchers found that targeted therapies matched to genomic alterations in ESCAT tier I/II significantly improved progression-free survival.
Most NCCN Radiotherapy Recommendations Not Backed by High-Level Evidence
Less than 10% of radiotherapy recommendations in 2020 NCCN guidelines were category 1 recommendations.
- Loading...
Loading...
Loading... 
Loading...